Key result
H.E.L.P.-apheresis in women with early-onset preeclampsia revealed highly accelerated lipid metabolism, with a serum lipid rebound half-time of 1.8 days and a shift to larger buoyant LDL subclasses.
Why the study?
Does repeated lipid apheresis alter serum lipid parameters and lipoprotein turnover in early onset preeclamptic patients?
Observational (n=6)
No
Does repeated lipid apheresis alter serum lipid parameters and lipoprotein turnover in early onset preeclamptic patients?
Lipid metabolism is highly accelerated in early onset preeclampsia, leading to rapid rebound of lipids after apheresis and potential accumulation of remnant lipoproteins.
Answers are grounded in this paper and cite their sources.
Rapid lipid rebound after apheresis may constrain session frequency in early preeclampsia; leaves open whether treatment alters outcomes.
Preeclampsia is a life-threatening disease in pregnancy, and its complex pathomechanisms are poorly understood. In preeclampsia, lipid metabolism is substantially altered. In late onset preeclampsia, remnant removal disease like lipoprotein profiles have been observed. Lipid apheresis is currently being explored as a possible therapeutic approach to prolong preeclamptic pregnancies. Here, apheresis-induced changes in serum lipid parameters are analyzed in detail and their implications for preeclamptic lipid metabolism are discussed. In the Freiburg H.E.L.P.-Apheresis Study, 6 early onset preeclamptic patients underwent repeated apheresis treatments. Serum lipids pre- and post-apheresis and during lipid rebound were analyzed in depth via ultracentrifugation to yield lipoprotein subclasses. The net elimination of Apolipoprotein B and plasma lipids was lower than theoretically expected. Lipids returned to previous pre-apheresis levels before the next apheresis even though apheresis was repeated within 2.9 ± 1.2 days. Apparent fractional catabolic rates and synthetic rates were substantially elevated, with fractional catabolic rates for Apolipoprotein B / LDL-cholesterol being 0.7 ± 0.3 / 0.4 ± 0.2 [day− 1] and synthetic rates being 26 ± 8 / 17 ± 8 [mg*kg− 1*day− 1]. The distribution of LDL-subclasses after apheresis shifted to larger buoyant LDL, while intermediate-density lipoprotein-levels remained unaffected, supporting the notion of an underlying remnant removal disorder in preeclampsia. Lipid metabolism seems to be highly accelerated in preeclampsia, likely outbalancing remnant removal mechanisms. Since cholesterol-rich lipoprotein remnants are able to accumulate in the vessel wall, remnant lipoproteins may contribute to the severe endothelial dysfunction observed in preeclampsia. ClinicalTrails.gov, NCT01967355 .
No takes yet. Share an insight, caveat, or question.
Contini et al. (2018) conducted an observational in Early-onset preeclampsia (n=6). H.E.L.P.-apheresis was evaluated on Rebound half-time (R50) of serum lipids (95% CI 1.1-2.4). H.E.L.P.-apheresis in women with early-onset preeclampsia revealed highly accelerated lipid metabolism, with a serum lipid rebound half-time of 1.8 days and a shift to larger buoyant LDL subclasses.
Synapse has enriched 10 related papers. Consider them for comparative context: